{
  "id": 15777969,
  "title": "Abu Dhabi gene therapy frees thalassaemia patient from more blood transfusions",
  "url": "https://urgent.news/2026/10/20/abu-dhabi-gene-therapy-frees-thalassaemia-patient-from-more-blood-15777969",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-20T17:25:33.000Z",
  "source": {
    "name": "The National UAE",
    "slug": "the-national-uae",
    "url": "https://www.thenationalnews.com/news/uae/2026/10/20/abu-dhabi-gene-therapy-frees-thalassaemia-patient-from-more-blood-transfusions/"
  },
  "original_language": "en",
  "account": "A 43-year-old man from Abu Dhabi, identified as Fahad, has achieved transfusion independence thanks to a groundbreaking gene therapy treatment. This development represents a significant medical breakthrough in the United Arab Emirates. For decades, Fahad endured the challenges of thalassaemia, a blood disorder that renders patients deficient in haemoglobin, the protein responsible for oxygen transport in the blood. This condition necessitated frequent transfusions every three to four weeks to maintain healthy haemoglobin levels and, consequently, required ongoing iron chelation therapy to manage iron overload. The UAE's Yas Clinic and Abu Dhabi Stem Cells Centre (ADSCC) played a pivotal role in Fahad's journey. About 18 months ago, he was referred to these institutions for cutting-edge gene therapy research aimed at treating thalassaemia. The treatment process began with the extraction of Fahad's own stem cells, which were then genetically modified to introduce corrective changes. Following subsequent therapy, these modified cells were reintroduced into Fahad's body. As a result, Fahad is no longer reliant on regular transfusions, marking a life-changing milestone in his treatment journey. Dr Maysoon Al Karam, the chief medical officer at Yas Clinic, highlighted the UAE's commitment to making advanced therapies accessible to domestic patients, viewing this as a milestone in expanding access to innovative treatments. Dr Mohammed Abu Haleeqa, a haematologist at Yas Clinic, emphasized the transformative impact gene therapy can have on patients who have traditionally depended on regular transfusions. This innovative treatment offers the potential to address the disease's root cause by utilizing the patient's own genetically modified cells, paving the way for more effective long-term solutions in managing thalassaemia.",
  "summary": "A thalassaemia patient in Abu Dhabi has become transfusion-independent following gene-therapy treatment, marking a medical milestone in the UAE. The 43-year-old patient, known only as Fahad, spent years managing transfusion-dependent thalassaemia, requiring treatment every three to four weeks to maintain stable haemoglobin levels. The condition also led to an overload or iron and a constant need…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The National Business",
        "title": "Abu Dhabi gene therapy frees thalassaemia patient from more blood transfusions",
        "url": "https://urgent.news/2026/10/20/abu-dhabi-gene-therapy-frees-thalassaemia-patient-from-more-blood",
        "published": "2026-10-20T17:25:33.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}